Rani Therapeutics
RANI
RANI
22 hedge funds and large institutions have $20.3M invested in Rani Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $19.6M → $20.3M (+$725K)
0.73% more ownership
Funds ownership: 5.57% → 6.3% (+0.73%)
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.87M | |
| 2 | +$679K | |
| 3 | +$344K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$68K |
| 5 |
Morgan Stanley
New York
|
+$61K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$999K | |
| 3 | -$517K | |
| 4 |
CH
Canton Hathaway
Providence,
Rhode Island
|
-$82K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$18K |